In Support of the Dialysis PATIENTS Demonstration Act (PATIENTS Act)
The Dialysis PATIENTS Demonstration Act (PATIENTS Act) proposed Federal legislation will deliver high-quality, integrated care to patients receiving dialysis for...
Transitioning from Part D to Part B: A Medicare Story
Author: Jeffrey L. Hymes, MD, CMO & SVP Following the U.S. Food and Drug Administration’s recent approval of Parsabiv™ (etelcalcetide),...
We Encourage Everyone to Say Thank You to a Nephrology Nurse
It takes a special kind of person to dedicate their life to taking care of others. Nephrology nurses help their...
Patient satisfaction is at an all-time high at FreseniusRx
Randell J. Correia, PharmD, FreseniusRx President FreseniusRx is proud to put patients first in all we do—our pharmacists focus specifically...
Intravenous Form of Sensipar® Has Been Approved by the FDA
Author: Jeffrey L. Hymes, MD, CMO & SVP Parsabiv™, an IV formulation similar to the oral calcimimetic Sensipar®, was recently...
Fresenius Medical Care Expands ESCO Participation
The Centers for Medicare & Medicaid Services recently announced the acceptance of 24 new markets into its ESRD Seamless Care...
2016 FreseniusRx Year in Review
At FreseniusRx, we understand that pharmacists are a critical part of our patients’ integrated care teams. Our pharmacists specialize in...
Fresenius Kidney Care Tops CMS Five-Star Ratings
Billy Kim, VP of Operations & Clinical Services The Centers for Medicare & Medicaid Services (CMS) recently issued its annual...
Healthcare Change Is Coming … But What Does That Mean for Me?
Robert Sepucha, Senior VP of Corporate Affairs for FMCNA These days, the question I hear most often is, “Who is...
CMS Initiative Opens Door to Integrate Pharmacists into Patient Care
Patrick Wilson, R.Ph., BCACP, CDE The Centers for Medicare & Medicaid Services (CMS) launched an initiative in October 2015 in...